IRadimed Corporation (NASDAQ:IRMD) Q4 2022 Earnings Call Transcript

Unidentified Analyst: Yes, yes. So great, well, that kudos to execution and management here, considering there has been a lot of upheaval under the surface, but it looks like you have managed to keep the surface calm and deliver to your customers. So great. Thanks for the color. That’s all I got.

Roger Susi: You’re welcome. Good to talk to you.

Unidentified Analyst: Thanks.

Operator: Thank you. I’m not showing any further questions at this time. I would now like to turn the call back over to Mr. Susi for any closing remarks.

Roger Susi: Thank you, Operator. Well, we couldn’t be more pleased to have had this opportunity to report such a strong gain for 2022 and to share our expectations for 2023. IRadimed is running very efficiently and its products are being adopted at an accelerating rate, with margins at levels of that many of our peers may envy. All company areas are growing, including new physical plant at a recently purchased site, which we are now designing to meet our continuing growth needs. With that, I look forward to reporting our future successes as the year progresses, and thank you all.

Operator: Ladies and gentlemen, this concludes the call. Thank you for participating. You may now disconnect.